文献速递关节外科

年龄对髌股关节置换术结局、骨关节炎进展和生存率的影响:最年轻和最年长者获得最佳结果

Impact of Age on Patello-femoral Arthroplasty Outcomes, Osteoarthritis Progression, and Survivorship: The Youngest and Oldest Achieve the Best Results.
PubMed 文献 · J Arthroplasty · 2025-06-21

回顾性分析120例第三代假体初次孤立性髌股关节置换术患者,平均随访8.6年,按年龄分四组。55岁以下组功能结局更优、骨关节炎进展轻微且生存率100%,76岁以上组生存率亦达100%;56至65岁组因骨关节炎进展生存率最低(90%)。

要点

  • 55岁以下患者髌股关节置换术后功能评分更优,中低冲击运动参与率92%,无显著骨关节炎进展。
  • 55岁以下组和76岁以上组假体生存率均为100%,56至65岁组最低为90%。
  • 作者认为髌股关节置换术对非常年轻和非常年老的孤立性髌股骨关节炎患者是有效治疗选择。

核心结论

  • 55岁以下患者行髌股关节置换术临床结局更优、骨关节炎进展轻微且生存率高。
  • 76岁以上患者亦表现出极好的生存率和满意的临床结局。
  • 56至65岁患者翻修风险最高。
  • 作者认为本研究支持髌股关节置换术作为非常年轻和非常年老孤立性髌股骨关节炎患者的治疗选择。

研究设计与样本

  • 回顾性分析接受第三代假体初次孤立性髌股关节置换术的患者,共120例髌股关节置换术,平均随访8.6年。
  • 按年龄分为四组:I组(小于55岁)、II组(56至65岁)、III组(66至75岁)、IV组(大于76岁)。

主要发现

  • I组功能结局显著优于较年长组,包括更高的膝关节协会评分、Tegner活动量表和加州大学洛杉矶分校活动评分(P < 0.01)。
  • I组中低冲击运动参与率最高(92%),且无显著骨关节炎进展。
  • I组和IV组假体生存率均为100%,II组因骨关节炎进展生存率最低(90%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Proper patient selection is essential to improve long-term outcomes in patellofemoral arthroplasty (PFA). This study aimed to assess the impact of age on functional outcomes, osteoarthritis (OA) progression, and survivorship in patients who underwent PFA using a modern implant. METHODS: Patients who underwent primary isolated PFA with third-generation prosthesis were retrospectively reviewed. A total of 120 PFAs with a mean follow-up of 8.6 years were included. Patients were categorized into four age groups: Group I (< 55 years), Group II (56 to 65 years), Group III (66 to 75 years), and Group IV (> 76 years). Clinical and radiographic outcomes included knee range of motion, Knee Society scores, University of California Los Angeles Activity Score, Tegner Activity Scale, OA progression, and patient satisfaction. Survival analysis was also conducted. RESULTS: Patients in Group I demonstrated significantly better functional outcomes, including higher Knee Society, Tegner, and University of California Los Angeles scores, compared to older groups (P < 0.01). Group I also showed the highest engagement in medium to low-impact sports (92%) and no significant OA progression. Groups I and IV had a 100% survivorship rate; in contrast, group II exhibited the lowest survivorship rate (90%) due to OA progression. CONCLUSIONS: A PFA in patients under 55 years resulted in superior clinical outcomes, minimal OA progression, and high survivorship rates. Even patients over 76 years demonstrated an excellent survival rate along with satisfactory clinical outcomes. Conversely, patients aged 56 to 65 years demonstrated the highest risk of revision. This study supports the effectiveness of PFA as a treatment option for isolated patello-femoral OA in very young and very old patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Marullo M, Bargagliotti M, Russo A, et al. Impact of Age on Patello-femoral Arthroplasty Outcomes, Osteoarthritis Progression, and Survivorship: The Youngest and Oldest Achieve the Best Results. J Arthroplasty. 2025. PMID: 40550375. doi:10.1016/j.arth.2025.06.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。